Browse by author
Lookup NU author(s): Dr Karim Bennaceur, Mark Atwill, Nayef Al Zhrany, Jedrzej Hoffmann, Professor Bernard Keavney, Professor Gavin RichardsonORCiD, Professor Thomas von Zglinicki, Dr Gabriele Saretzki, Professor Ioakim SpyridopoulosORCiD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).
Statins are one of the most potent drugs in delaying age-related inflammatory changes in the arterial vessel wall, slowing down the progression of atherosclerosis. Statins have also been shown to abrogate telomere-attributed cardiovascular risk. The goal of our study was to explore a potential effect of atorvastatin on telomerase activity in peripheral blood mononuclear cells (PBMCs) and T-lymphocytes (T cells).
Author(s): Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, Breault D, Richardson G, von Zglinicki T, Saretzki G, Spyridopoulos I
Publication type: Article
Publication status: Published
Journal: Atherosclerosis
Year: 2014
Volume: 236
Issue: 2
Pages: 312-320
Print publication date: 01/10/2014
Online publication date: 04/08/2014
Acceptance date: 21/07/2014
Date deposited: 04/08/2015
ISSN (print): 0021-9150
ISSN (electronic): 1879-1484
Publisher: Elsevier Ireland Ltd.
URL: http://dx.doi.org/10.1016/j.atherosclerosis.2014.07.020
DOI: 10.1016/j.atherosclerosis.2014.07.020
PubMed id: 25127175
Altmetrics provided by Altmetric
